Shenzhen Weiguang Biological Partners with SUAT to Boost Life Science and Health Industry
Shenzhen Weiguang Biological Products Co., Ltd. (SHE: 002880), a prominent blood products manufacturer in China,...
Deals
C-Ray Therapeutics Secures Over $100 Million in Series A+ Financing for Radiopharmaceuticals
C-Ray Therapeutics, a specialist in radiopharmaceuticals headquartered in Chengdu, has announced the successful completion of...
Impact Therapeutics Secures $34.5 Million in Series D++ Financing for Senaparib Commercialization
China-based biopharmaceutical company Impact Therapeutics has reportedly secured RMB 250 million (USD 34.5 million) in...
J&J MedTech Secures Exclusive Distribution Deal with Responsive Arthroscopy
Johnson & Johnson (J&J, NYSE: JNJ) MedTech, a leading player in the US medical technology...
Beijing Biostar Partners with Baheal for Utidelone Market Promotion in China
Beijing Biostar Technologies Ltd (HKG: 2563), a synthetic biology-driven anti-tumor drug specialist that made its...
PegBio Files for IPO on Hong Kong Stock Exchange
PegBio Co., Ltd., a specialist in endocrine metabolism based in Suzhou, has taken a significant...
Cullgen and Pulmatrix Merge to Form Nasdaq-Listed Protein Degradation Company
Cullgen Inc., a clinical-stage biopharmaceutical company with operations in China, the US, and Japan, is...
Zucara Therapeutics Secures $20M Series B Financing Led by Sanofi and PXV Fund
Canada-based diabetes life sciences company, Zucara Therapeutics Inc., has announced the receipt of a strategic...
Zhejiang Dian Diagnostics Partners with SNN/CRHA for Optic Nerve Disease Research
China-based Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a leading diagnostic solutions provider, has formed...
BioNTech Seals Acquisition of China’s Biotheus for Up to $950M
China’s Biotheus Inc. has entered into a definitive acquisition agreement with Germany-based BioNTech SE (NASDAQ:...
Arctic Vision and Santen Ink Deal for ARVN001 Commercialization in China
China-based ophthalmology specialist, Arctic Vision, has entered into a strategic collaboration with Japan’s Santen Pharmaceutical...
Sunshine Lake Pharma Inks Licensing Deal with Apollo Therapeutics for APL-18881
China-based Sunshine Lake Pharma Co., Ltd., (HKG: 1558) a member of the HEC Group, has...
Sihuan Pharmaceutical Plans IPO for Xuanzhu Biopharm on Hong Kong Stock Exchange
China’s Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) has announced a renewed attempt to spin...
Boehringer Ingelheim Joins MTM Vision Consortium to Advance Diabetes Retinopathy Research
Germany-based pharmaceutical major Boehringer Ingelheim has announced the initiation of a long-term collaboration with the...
Canhelp Genomics Partners with Mirxes to Expand Tumor Origin Testing in Southeast Asia
Canhelp Genomics, a Chinese company specializing in oncology-focused molecular diagnostics, has formed a strategic partnership...
Vesalius Therapeutics Partners with GSK for Novel Parkinson’s Disease Treatments
US-based Vesalius Therapeutics has entered into a strategic agreement with UK pharmaceutical giant GSK plc...
Flare Therapeutics and Roche Enter Strategic Collaboration for Oncology Drug Discovery
US-based Flare Therapeutics Inc., a clinical-stage biotech company specializing in cancer therapies through the use...
Schrödinger and Novartis Ink Deal to Accelerate Drug Discovery Candidates
New York-based Schrödinger, Inc. (NASDAQ: SDGR), a leading software provider in accelerating drug discovery, has...
Triton Partners Mulls Acquisition of Germany’s Evotec SE, Shares Soar 22%
Private equity firm Triton Partners is reportedly contemplating the acquisition of Germany-based Evotec SE (NASDAQ:...
Leman Biotech Secures Over USD 13.9 Million in Series A Financing for Next-Gen Cancer Immunotherapies
China-based Leman Biotech Co., Ltd. has reportedly completed the first closing of its Series A...